Radiologists Can Help ID Intimate Partner Violence
TUESDAY, Feb. 5, 2019 -- Victims of intimate partner violence (IPV) undergo more imaging procedures than age- and sex-matched control patients and are more likely to have obstetric-gynecologic findings and acute fractures, according to a study published online Feb. 5 in Radiology.
Elizabeth George, M.D., from Brigham and Women's Hospital in Boston, and colleagues reviewed the electronic medical records of 185 patients referred to the IPV support program from the emergency department. The records were compared with an age- and sex-matched control group of 555 patients who presented to the emergency department.
The researchers found that 96.2 percent of patients who experienced IPV were female and 37.3 percent were African-American. Race, psychiatric comorbidities, and homelessness were independently associated with IPV (odds ratios, 3.2 to 5.9, 5.4, and 13.0, respectively). Compared with controls, IPV victims underwent more imaging studies in the preceding five years (median, four versus one). Independent associations with IPV were seen for obstetric-gynecologic findings and acute fractures seen on images (odds ratios, 4.4 and 2.4, respectively). The area under the receiver operating characteristic curve (AUC) of the multivariate model to detect IPV was increased with the addition of imaging findings to demographic and clinical variables (0.87 versus 0.86); an AUC of 0.85 was seen in the cross-validated multivariate model.
"Our study suggests that these otherwise common findings could be indicative of intimate partner violence in the setting of specific socioeconomic factors identified in our study," George said in a statement.
© 2020 HealthDay. All rights reserved.
Posted: February 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.